Drugs in the COVID-19 pandemic: Analysis of the commercialization of azithromycin, hydroxychloroquine, ivermectin and nitazoxanide in Brazil. RSD [Internet]. 2022 Apr. 24 [cited 2025 Dec. 5];11(6):e16711628726. Available from: https://rsdjournal.org/rsd/article/view/28726